In vivo immunosuppression by targeting a novel protease receptor

Nature
M A DuchosalD C Altieri

Abstract

Membrane receptors for blood proteases govern the clotting and fibrinolytic cascades, regulate signal transduction and control the growth of mesenchymal cells. Despite their importance in the development of vascular injury, it is unclear whether these mechanisms participate in the generation of an immune response. Here we report that targeting a factor Xa receptor, designated effector cell protease receptor-1 (EPR-1), with antisense oligonucleotide or with a monoclonal antibody (mAB 2E1) inhibited CD3/T-cell receptor-dependent lymphocyte proliferation. Immunosuppression was mediated by abolishing cytokine production and down-modulating membrane expression of the interleukin (IL)-2 receptor. In vivo administration of mAb 2E1 to severe-combined-immunodeficient mice injected with human peripheral blood leukocytes suppressed production of human immunoglobulin, abolished graft-versus-host disease, and protected these xenochimaeric mice from Epstein-Barr-virus-induced human lymphoproliferative disease. These observations indicate a new role for protease receptors in the regulation of the immune response, and identify a potential target for therapeutic immunosuppression in humans.

References

Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·G P GasicG J Gasic
Oct 10, 1991·Nature·D E MosierD B Wilson
Oct 29, 1991·Biochemistry·E W DavieW Kisiel
Sep 1, 1990·The Journal of Experimental Medicine·M A DuchosalF J Dixon
Mar 16, 1989·Nature·D E MosierD B Wilson
Jun 1, 1993·Current Opinion in Immunology·M K Jenkins, J G Johnson
Jun 1, 1993·Current Opinion in Immunology·C A Janeway, P Golstein

❮ Previous
Next ❯

Citations

Jun 13, 2001·Biochemical and Biophysical Research Communications·A KawabataN Kawao
Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·S T SmileyM J Grusby
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·A L Rothermel, D C Altieri
Jul 2, 2005·Expert Opinion on Emerging Drugs·Omer IqbalWilliam Wehrmacher
Jul 16, 2004·Kidney International·Malcolm A CunninghamStephen R Holdsworth
Mar 28, 1996·Nature·M Trucco, G Stassi
Aug 16, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Karen E Welty-WolfClaude A Piantadosi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.